immunology

News

Merck puts $1.3bn into AI via Exscientia, BenevolentAI deals

German group Merck has revved up its artificial intelligence-powered drug discovery with partnerships with two UK companies – Exscientia and BenevolentAI – that will focus

Oncology

CAR-TCR 2023 – Greg Deener

In late August, pharmaphorum traveled to Boston to cover CAR-TCR, a conference dedicated to the fast-moving cell therapy space.

News

3d illustration of molecule model. Science background with molecules and atoms

AbbVie, Anima Biotech announce collaboration worth $580M plu...

AbbVie and Anima Biotech have

News

ACELYRIN acquires ValenzaBio, strengthens immunology positio...

ACELYRIN, Inc., a Los Angeles area-based, late-stage clinical biopharma, with additional operations in the San Francisco Bay area,

News

Merck pledges revamp of R&D to drive productivity

Germany's Merck KGaA has said it needs to double the productivity of its R&D operations, with the aim of launching a new product every 18 months on average, to boost its pharma business

News